“A Day of Results”: Senate Passes Compounding/Track & Trace
This article was originally published in RPM Report
Executive Summary
On November 18, the Senate enacted passed H.R. 3204
, the Drug Quality and Security Act by a voice vote, and the new pharmacy compounding/supply chain security bill is set to be signed into law. One of the key reasons for that was the support from Senate Health Subcommittee ranking member, Lamar Alexander, whose home state experienced a disproportionate impact from the meningitis outbreak traced back to compounded products. Here are his remarks on the Senate floor immediately after the vote.
You may also be interested in...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.